This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.

The bipolar disorder (BD) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and ...

Roche has received EC approval for its humanised monoclonal antibody Gazyva, in combination with mycophenolate mofetil (MMF).

Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

Agilent Technologies has expanded its collaboration with Monash University Malaysia (MUM) for the establishment of a ...

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

Viatris has signed definitive agreements for the sale of its equity stake in Biocon Biologics to Biocon for $815m.

On 1 December, the fortunes of the UK pharma sector changed radically, with the UK Government becoming the first in the world ...

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.